Dupilumab May Simplify Chronic Spontaneous Urticaria Treatment

(MedPage Today) -- In this exclusive MedPage Today video, Thomas B. Casale, MD, of the University of South Florida in Tampa, discusses new analyses from the LIBERTY-CUPID studies evaluating dupilumab (Dupixent) in chronic spontaneous urticaria...
Source
MedPage Today
Opens original article in a new tab



